|
Wednesday, October 6, 2010 | 8:30 AM - 7:00 PM | Recently uncovered genetics defects predispose to Parkinson’s disease and new animal models better mimic human disease. This upcoming conference will examine recent advances in the understanding and treatment of this neurodegenerative disorder. More
Estrogens play a role in memory processes, yet molecular mechanisms and the role of estrogen receptors remain unclear. This meeting discussed estrogen signaling for memory formation and advances in dissecting out the pathways underlying these effects. More
This Annals volume examines various approaches to neuroprotection, including methods for neuroprotection, mechanisms involved in neuroinjury, and pharmacologic agents associated with neuroprotection.
More
-
September 23 - 25, 2010
Keynote Speaker: Apostolos P. Georgopoulos (University of Minnesota Medical School)
Neural prosthetic devices to replace motor, sensory, and cognitive function lost by disease or trauma hold great therapeutic promise but have not been widely used in people. This conference will examine how to use neural prosthetics therapeutically.
Wednesday, October 6, 2010 | 8:30 AM - 7:00 PM
Chair: Franz Hefti, PhD (Avid Radiopharmaceuticals)
This conference will highlight novel and innovative therapeutic targets for Parkinson’s Disease, biomarkers for early detection and assessment of disease progression, and emerging strategies to alleviate symptoms and/or to slow disease progression.
Tuesday, October 26, 2010 | 1:00 PM - 5:00 PM
Speakers: Katerina Akassoglou (Gladstone Institute & UCSF), Andrew Miller (Emory University School of Medicine), Malú Tansey (Emory University School of Medicine), Shi Du Yan (Columbia University) and Raz Yirmiya (Hebrew University)
Breakthroughs spanning neuroscience and immunology are rare, as they do not share a common language or purpose. This symposium highlights recent discoveries in clinical depression, the stress response, Alzheimer's and multiple sclerosis.
October 29 - 30, 2010
Organizers: Barry Lester (Warren Alpert Medical School of Brown University), Edward Tronick (University Massachusetts Boston and Children's Hospital Boston), and Eric Nestler (Mount Sinai School of Medicine)
This 2-day CME- and CE-accredited conference will focus on the quest to understand how environmental factors affect behavioral outcomes (learning, memory, mental illness, normal development and developmental psychopathology) via epigenetic modulation.
Tuesday, November 9, 2010 | 7:00 PM - 8:30 PM
Speakers: Nicholas Carr, Nicholas Toth (The Stone Age Institute)
Humans have long modified our world through tools and technology. But how do the tools modify us? Join Nicholas Carr, author of The Shallows: What the Internet is Doing to Our Brains. With an introduction by Stone Age anthropologist, Nicholas Toth.
Tuesday, May 25, 2010 | 1:00 PM - 5:00 PM
Speakers: Enikö Kramár (University of California, Irvine), Feng Liu (Pfizer), Bruce McEwen (Rockefeller University), and John Morrison (Mount Sinai School of Medicine)
Estrogens play a role in memory processes, yet molecular mechanisms and the role of estrogen receptors remain unclear. This meeting discusses estrogen signaling for memory formation and advances in dissecting out the pathways underlying these effects.
Thursday, May 13, 2010 | 8:30 AM - 5:00 PM
Organizers: Howard Fillit (Alzheimer's Drug Discovery Foundation) and Sonya Dougal (The New York Academy of Sciences)
Please join us for a critical discussion of potential drug therapeutics for mitochondrial dysfunction in Alzheimer's disease.
May 9 - 10, 2010
Organizers: Gregory J. del Zoppo (University of Washington School of Medicine) and Philip B. Gorelick (University of Illinois College of Medicine at Chicago School of Medicine)
This 1.5-day conference will address recent advancements, challenges, and future directions in research studying innate inflammation as a risk factor leading to transient ischemic attacks and stroke, and their potential implications with respect to therapy and prevention.
Tuesday, April 27, 2010 | 9:00 AM - 5:00 PM
Organizers: Chad E. Beyer (University of Colorado School of Medicine), Mark R. Bowlby (Merck Research Laboratories), Ildiko Antal (Bristol-Myers Squibb), Beth Winkelstein (University of Pennsylvania), Jennifer Henry (The New York Academy of Sciences)
This symposium addresses clinical applications and new pain mechanisms for the treatment of chronic pain syndromes, and provides an update on the progress and barriers to developing effective preclinical models of pain, in particular fibromyalgia.
|
-
Annals
Edited by Jack D. Barchas and JoAnn Difede (Weil Medical College of Cornell University, New York, NY)
This Annals volume includes manuscripts from the 89th Annual Conference for Research in Nervous and Mental Disease entitled "Psychiatric and Neurologic Aspects of War" held at Rockefeller University on December 16, 2009.
Forthcoming issue
Annals
Edited by Mark F. Mehler (Albert Einstein College of Medicine of Yeshiva University, Bronx, New York) and Dolores Malaspina (New York State Psychiatric Institute, Columbia University, New York, New York)
This Annals on-line only issue stems from the Association for Research in Nervous and Mental Disease 88th Annual Conference entitled "Epigenetics and Neuropsychiatric Diseases: Mechanisms Mediating Nature and Nurture" held December 5, 2008 at the New York Academy of Medicine.
Volume 1204 S1
eBriefing
Speakers: Enikö Kramár (University of California, Irvine), Feng Liu (Pfizer), Bruce McEwen (The Rockefeller University), and John Morrison (Mount Sinai School of Medicine)
Organizers: Feng Liu (Pfizer) and Jennifer Henry (The New York Academy of Sciences)
Estrogens play a role in memory processes, yet molecular mechanisms and the role of estrogen receptors remain unclear. This meeting discussed estrogen signaling for memory formation and advances in dissecting out the pathways underlying these effects.
eBriefing
Organizers: Howard Fillit (Alzheimer's Drug Discovery Foundation) and Sonya Dougal (The New York Academy of Sciences)
Damage to energy-producing organelles may lead to a cascade of events resulting in Alzheimer's disease. Insights into this process and the possibility of new drug targets were the topic of an Academy symposium.
eBriefing
Organizers: Ildiko Antal (Bristol-Myers Squibb), Chad E. Beyer (University of Colorado School of Medicine), Mark R. Bowlby (Merck Research Laboratories), Beth Winkelstein (University of Pennsylvania), and Jennifer Henry (The New York Academy of Sciences)
This symposium addressed clinical applications and new pain mechanisms for the treatment of chronic pain syndromes, and provided an update on the progress and barriers to developing effective preclinical models of pain, in particular fibromyalgia.
Webinar Archive
February 23, 2010
Researchers met to discuss advances in basic and translational research on metabotropic glutamate receptors, which are promising targets in drug discovery for CNS diseases and other illnesses.
Webinar Archive
October 27, 2009
What is the connection between dysregulated neuronal insulin signaling and Alzheimer's disease? In a recent Academy webinar, some researchers argued that the neurodegenerative disease should be considered a type of diabetes.
|
|
|